Company Overview

Light AI Inc. (OTC: OHCFF) is a technology company focused on applying artificial intelligence and optical sensing technologies to healthcare and diagnostic applications. Based on publicly available disclosures and market materials, the company has concentrated on developing software-driven diagnostic tools that use imaging, machine learning, and mobile-device integration to support rapid screening and health assessment workflows. Public information indicates the company operates primarily within the digital health, medical technology, and AI-enabled diagnostics sectors.

The company’s primary business focus appears to center on AI-assisted detection and screening technologies intended for healthcare providers, clinics, and potentially consumer health applications. Available public records suggest that Light AI has pursued positioning around low-cost, scalable diagnostics using smartphone-compatible or optical-analysis platforms. Historical public information regarding the company’s earlier corporate structure, predecessor entities, or complete evolution is limited across major filings and market databases. Data inconclusive based on available public sources regarding the full corporate history and long-term revenue composition.

Business Operations

Light AI’s operations appear to be centered on research, development, commercialization planning, and intellectual-property development related to AI-enabled healthcare screening technologies. Publicly available company materials indicate that the business model is oriented toward software licensing, platform commercialization, strategic healthcare partnerships, and potential diagnostic-service deployment. The company’s operational footprint appears relatively early-stage compared with larger established healthcare technology firms, with a strong emphasis on product development and validation activities.

Available disclosures indicate the company’s operations are primarily concentrated in North America, with a focus on technology development rather than large-scale manufacturing or multinational clinical infrastructure. Public information does not clearly identify extensive operating subsidiaries, major joint ventures, or large international business units. Data inconclusive based on available public sources regarding material revenue segmentation, significant commercial contracts, or major controlled assets beyond proprietary software and AI-related healthcare technology initiatives.

Strategic Position & Investments

Light AI’s strategic direction appears focused on expanding AI-driven healthcare diagnostics through scalable mobile and optical-analysis technologies. Public-facing materials suggest the company is pursuing opportunities in rapid screening, digital health accessibility, and machine-learning-supported diagnostic interpretation. Its positioning is aligned with broader healthcare trends emphasizing decentralized testing, telehealth integration, and lower-cost clinical assessment tools.

The company has emphasized technology development and validation as core strategic priorities. Available disclosures reference ongoing investment in AI algorithms, imaging systems, and healthcare application development. However, there is limited independently verified public information regarding large-scale acquisitions, material portfolio investments, or major subsidiary ownership structures. Data inconclusive based on available public sources concerning substantial mergers and acquisitions activity or ownership of significant portfolio companies.

Geographic Footprint

Public disclosures indicate that Light AI maintains its principal operational presence in Canada, while its shares also trade in U.S. over-the-counter markets through the OHCFF ticker. The company’s strategic market interest appears focused on North America, particularly healthcare and diagnostic markets where AI-assisted screening technologies may have commercial application.

Although the company’s technology concepts may have broader international relevance, publicly verified information regarding substantial operating infrastructure outside Canada and the United States remains limited. Data inconclusive based on available public sources concerning material operational presence across Europe, Asia-Pacific, Latin America, or other international regions.

Leadership & Governance

Public filings and market disclosures indicate that Light AI is led by an executive management team focused on healthcare innovation, AI commercialization, and technology development. Due to limited consistency across publicly available databases and evolving company disclosures, some executive and governance information could not be fully verified across multiple independent sources.

Known or publicly referenced leadership figures include:

• Peter Whitehead – Chief Executive Officer
• Data inconclusive based on available public sources regarding a fully verified current executive leadership roster and complete board composition.

The company’s publicly communicated strategic vision has emphasized the use of artificial intelligence to improve accessibility, scalability, and efficiency in healthcare diagnostics and screening workflows. Available governance information suggests a technology commercialization focus, though detailed governance practices and long-term executive strategy frameworks are not comprehensively disclosed in widely available public filings.